Truist Securities Maintains Buy on Doximity, Lowers Price Target to $37
Doximity, Inc. Class A -1.81%
Doximity, Inc. Class A DOCS | 22.25 | -1.81% |
Truist Securities analyst Jailendra Singh maintains Doximity (NYSE:
DOCS) with a Buy and lowers the price target from $62 to $37.
